Razer Faces Refunds Over Zephyr Smart Mask Misrepresentation

Razer is now issuing refunds for its Zephyr smart masks following a settlement with the United States Federal Trade Commission (FTC). The company introduced the high-tech wearable, initially part of 'Project Hazel,' in 2021, promising advanced protection against viruses and particles. However, the FTC disputed Razer's claims that the Zephyr functioned as an N95 respirator,…

Alexis Wang Avatar

By

Razer Faces Refunds Over Zephyr Smart Mask Misrepresentation

Razer is now issuing refunds for its Zephyr smart masks following a settlement with the United States Federal Trade Commission (FTC). The company introduced the high-tech wearable, initially part of 'Project Hazel,' in 2021, promising advanced protection against viruses and particles. However, the FTC disputed Razer's claims that the Zephyr functioned as an N95 respirator, leading to a significant lawsuit. As a result, Razer agreed to a settlement exceeding $1 million, with the funds allocated to reimburse affected customers.

Razer marketed the Zephyr smart mask at a price of $100 each between late 2021 and early 2022. The mask featured a transparent mouth area and customizable RGB lights, appealing to tech enthusiasts. Nevertheless, the central claim that the mask provided "N95-grade" filtration similar to respirators capable of blocking up to 95 percent of air and water particles came under scrutiny.

The FTC challenged these assertions in their lawsuit against Razer, highlighting the deceptive marketing practices surrounding the Zephyr smart mask. The government agency argued that Razer's misleading claims exploited public fears during the COVID-19 pandemic by promising more protection than the product could deliver.

In a settlement agreement, Razer consented to pay $1,071,254.33 and an additional $100,000 fine for its actions. This settlement aims to refund the approximately 6,764 customers affected by the misleading advertising. Refunds will be dispensed through checks or PayPal payments, allowing consumers to reclaim their expenditures on the misrepresented product.

The FTC emphasized that this case serves as a reminder for companies to ensure transparency and accuracy in marketing health-related products. It underscores the importance of consumer protection, particularly during times when public health concerns are at a peak.

Alexis Wang Avatar